LGVAX vs. SMVLX

Last updated Jun 4, 2026

LGVAX (ClearBridge Value Fund Class A) and SMVLX (Smead Value Fund) are both Large Cap Value Equities funds. Over the past 10 years, LGVAX returned 12.07%/yr vs 12.13%/yr for SMVLX. Their correlation of 0.88 suggests significant overlap in exposure. LGVAX charges 1.01%/yr vs 1.26%/yr for SMVLX.

Performance

LGVAX vs. SMVLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ClearBridge Value Fund Class A (LGVAX) and Smead Value Fund (SMVLX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LGVAX achieves a 11.52% return, which is significantly lower than SMVLX's 13.63% return. Both investments have delivered pretty close results over the past 10 years, with LGVAX having a 12.07% annualized return and SMVLX not far ahead at 12.13%.

LGVAX

• 1D: 0.42%
• 1M: 2.51%
• YTD: 11.52%
• 6M: 12.84%
• 1Y: 24.30%
• 3Y*: 17.22%
• 5Y*: 9.92%
• 10Y*: 12.07%

SMVLX

• 1D: 0.61%
• 1M: 0.39%
• YTD: 13.63%
• 6M: 11.21%
• 1Y: 28.87%
• 3Y*: 13.91%
• 5Y*: 9.52%
• 10Y*: 12.13%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LGVAX vs. SMVLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LGVAX ClearBridge Value Fund Class A	11.52%	10.56%	15.04%	19.69%	-6.33%	27.81%	11.40%	27.04%	-12.93%	14.59%
SMVLX Smead Value Fund	13.63%	5.05%	4.78%	16.87%	-2.79%	42.46%	1.71%	26.29%	-4.79%	19.73%

Correlation

The correlation between LGVAX and SMVLX is 0.65, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.65
Correlation (3Y) Calculated over the trailing 3-year period	0.79
Correlation (5Y) Calculated over the trailing 5-year period	0.84
Correlation (10Y) Calculated over the trailing 10-year period	0.85
Correlation (All Time) Calculated using the full available price history since Feb 3, 2009	0.88

Over the past year, the correlation between LGVAX and SMVLX has dropped to 0.65 - well below their long-term average of 0.88, suggesting their price drivers have been diverging.

Return for Risk

LGVAX vs. SMVLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LGVAX

LGVAX Risk / Return Rank: 55
LGVAX Sharpe Ratio Rank: 49
LGVAX Sortino Ratio Rank: 46
LGVAX Omega Ratio Rank: 46
LGVAX Calmar Ratio Rank: 70
LGVAX Martin Ratio Rank: 62

SMVLX

SMVLX Risk / Return Rank: 67
SMVLX Sharpe Ratio Rank: 54
SMVLX Sortino Ratio Rank: 57
SMVLX Omega Ratio Rank: 50
SMVLX Calmar Ratio Rank: 93
SMVLX Martin Ratio Rank: 81

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LGVAX vs. SMVLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ClearBridge Value Fund Class A (LGVAX) and Smead Value Fund (SMVLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LGVAX	SMVLX	Difference
Sharpe ratio: Return per unit of total volatility	2.06	2.17	-0.11
Sortino ratio: Return per unit of downside risk	2.87	3.17	-0.31
Omega ratio: Gain probability vs. loss probability	1.37	1.38	-0.01
Calmar ratio: Return relative to maximum drawdown	3.24	5.20	-1.97
Martin ratio: Return relative to average drawdown	12.32	15.13	-2.81
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LGVAX vs. SMVLX - Sharpe Ratio Comparison

The current LGVAX Sharpe Ratio is 2.06, which is comparable to the SMVLX Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of LGVAX and SMVLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LGVAX	SMVLX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.06	2.17	-0.11
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.56	0.52	+0.04
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.63	0.63	0.00
Sharpe Ratio (All Time) Calculated using the full available price history	0.68	0.70	-0.02

Drawdowns

LGVAX vs. SMVLX - Drawdown Comparison

The maximum LGVAX drawdown since its inception was -40.40%, roughly equal to the maximum SMVLX drawdown of -39.56%. Use the drawdown chart below to compare losses from any high point for LGVAX and SMVLX.

Drawdown Indicators

	LGVAX	SMVLX	Difference
Max Drawdown Largest peak-to-trough decline	-40.40%	-39.56%	-0.84%
Max Drawdown (1Y) Largest decline over 1 year	-7.81%	-5.90%	-1.91%
Max Drawdown (3Y) Largest decline over 3 years	-19.09%	-24.62%	+5.53%
Max Drawdown (5Y) Largest decline over 5 years	-20.41%	-24.62%	+4.21%
Max Drawdown (10Y) Largest decline over 10 years	-40.40%	-39.56%	-0.84%
Current Drawdown Current decline from peak	0.00%	-0.64%	+0.64%
Average Drawdown Average peak-to-trough decline	-5.21%	-4.59%	-0.62%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.05%	2.03%	+0.02%

Volatility

LGVAX vs. SMVLX - Volatility Comparison

ClearBridge Value Fund Class A (LGVAX) has a higher volatility of 3.31% compared to Smead Value Fund (SMVLX) at 2.85%. This indicates that LGVAX's price experiences larger fluctuations and is considered to be riskier than SMVLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LGVAX	SMVLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.31%	2.85%	+0.46%
Volatility (6M) Calculated over the trailing 6-month period	9.10%	8.94%	+0.16%
Volatility (1Y) Calculated over the trailing 1-year period	12.26%	14.15%	-1.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.73%	18.36%	-0.63%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.25%	19.47%	-0.22%

LGVAX vs. SMVLX - Expense Ratio Comparison

LGVAX has a 1.01% expense ratio, which is lower than SMVLX's 1.26% expense ratio.

Dividends

LGVAX vs. SMVLX - Dividend Comparison

LGVAX's dividend yield for the trailing twelve months is around 9.65%, more than SMVLX's 1.47% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LGVAX ClearBridge Value Fund Class A	9.65%	10.76%	10.83%	12.64%	8.49%	18.44%	6.01%	0.54%	1.86%	0.50%	0.93%	0.39%
SMVLX Smead Value Fund	1.47%	1.67%	1.08%	1.34%	1.78%	3.91%	1.40%	3.83%	7.47%	0.22%	3.14%	3.10%

Frequently Asked Questions

Can I hold both LGVAX and SMVLX in my portfolio?

LGVAX and SMVLX have a correlation of 0.65, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LGVAX or SMVLX?

LGVAX has higher volatility (3.31%) compared to SMVLX (2.85%). In terms of maximum drawdown, LGVAX dropped -40.40% vs SMVLX's -39.56%.

Which has better risk-adjusted returns?

SMVLX currently has the higher Sharpe Ratio (2.17 vs 2.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.